Financhill
Sell
29

IMKTA Quote, Financials, Valuation and Earnings

Last price:
$66.21
Seasonality move :
5.25%
Day range:
$66.15 - $67.74
52-week range:
$59.73 - $89.59
Dividend yield:
1%
P/E ratio:
7.89x
P/S ratio:
0.22x
P/B ratio:
0.81x
Volume:
333.6K
Avg. volume:
124.3K
1-year change:
-22.04%
Market cap:
$1.3B
Revenue:
$5.9B
EPS (TTM):
$8.40
Period Ending 2019-09-30 2020-09-30 2021-09-30 2022-09-30 2023-09-30
Revenue $4.2B $4.6B $5B $5.7B $5.9B
Revenue Growth (YoY) 2.67% 9.72% 8.18% 13.85% 3.77%
 
Cost of Revenues $3.2B $3.4B $3.7B $4.3B $4.5B
Gross Profit $1B $1.2B $1.3B $1.4B $1.4B
Gross Profit Margin 24.32% 25.99% 26.13% 24.93% 23.84%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $873.9M $921.7M $963.3M $1B $1.1B
Other Inc / (Exp) $5.9M -$929.2K $11.8M $7.2M $11M
Operating Expenses $873.9M $921.7M $963.3M $1B $1.1B
Operating Income $148.1M $276.5M $340.1M $375.6M $289.5M
 
Net Interest Expenses $47.4M $40.5M $24.3M $21.5M $22.1M
EBT. Incl. Unusual Items $106.6M $235M $327.6M $361.3M $278.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $25M $56.4M $77.9M $88.5M $67.7M
Net Income to Company $81.6M $178.6M $249.7M $272.8M $210.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $81.6M $178.6M $249.7M $272.8M $210.8M
 
Basic EPS (Cont. Ops) $4.14 $9.06 $13.06 $14.69 $11.35
Diluted EPS (Cont. Ops) $4.03 $8.82 $12.73 $14.36 $11.10
Weighted Average Basic Share $20.3M $20.3M $19.6M $19M $19M
Weighted Average Diluted Share $20.3M $20.3M $19.6M $19M $19M
 
EBITDA $266.5M $391.9M $469.1M $500.6M $416.6M
EBIT $154M $275.6M $351.9M $382.8M $300.6M
 
Revenue (Reported) $4.2B $4.6B $5B $5.7B $5.9B
Operating Income (Reported) $148.1M $276.5M $340.1M $375.6M $289.5M
Operating Income (Adjusted) $154M $275.6M $351.9M $382.8M $300.6M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue $1.2B $1.3B $1.5B $1.4B $1.4B
Revenue Growth (YoY) 11.99% 7.39% 14.15% -1.67% -2.81%
 
Cost of Revenues $864.9M $940M $1.1B $1.1B $1.1B
Gross Profit $324.7M $337.5M $351.9M $338.1M $329.8M
Gross Profit Margin 27.3% 26.42% 24.13% 23.58% 23.66%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $234.6M $239.4M -- -- --
Other Inc / (Exp) $2M $2.1M $1.2M $2.2M $4.2M
Operating Expenses $234.6M $239.4M $257.3M $270.9M $286.3M
Operating Income $90.1M $98.1M $94.5M $67.2M $43.5M
 
Net Interest Expenses $9.7M $5.5M $5.3M $5.4M $5.4M
EBT. Incl. Unusual Items $82.4M $94.7M $90.5M $64M $42.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $19.6M $22.7M $22.7M $15.7M $10.6M
Net Income to Company $62.8M $72M $67.8M $48.3M $31.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $62.8M $72M $67.8M $48.3M $31.7M
 
Basic EPS (Cont. Ops) $3.18 $3.88 $3.65 $2.60 $1.71
Diluted EPS (Cont. Ops) $3.10 $3.79 $3.57 $2.54 $1.67
Weighted Average Basic Share $20.3M $19M $19M $19M $19M
Weighted Average Diluted Share $20.3M $19M $19M $19M $19M
 
EBITDA $121M $130.9M $125M $98.3M $77.2M
EBIT $92.1M $100.2M $95.8M $69.4M $47.7M
 
Revenue (Reported) $1.2B $1.3B $1.5B $1.4B $1.4B
Operating Income (Reported) $90.1M $98.1M $94.5M $67.2M $43.5M
Operating Income (Adjusted) $92.1M $100.2M $95.8M $69.4M $47.7M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue $4.5B $4.8B $5.6B $5.8B $5.8B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $3.4B $3.6B $4.2B $4.4B $4.5B
Gross Profit $1.1B $1.3B $1.4B $1.4B $1.4B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $907.2M $951.2M -- -- --
Other Inc / (Exp) $2.6M $1.9M $12.6M $8.6M $23.8M
Operating Expenses $907.2M $951.2M $1B $1.1B $1.2B
Operating Income $226.9M $335.4M $371.2M $316M $209.9M
 
Net Interest Expenses $43.4M $26.8M $22.3M $21.5M $22.6M
EBT. Incl. Unusual Items $186.1M $310.5M $361.5M $303.1M $211.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $44.5M $74.6M $87.2M $74.7M $51.5M
Net Income to Company $141.7M $235.9M $274.3M $228.3M $159.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $141.7M $235.9M $274.3M $228.3M $159.7M
 
Basic EPS (Cont. Ops) $7.19 $12.20 $14.78 $12.29 $8.59
Diluted EPS (Cont. Ops) $7.00 $11.89 $14.44 $12.01 $8.40
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $344.8M $458.2M $498.6M $440.7M $350.4M
EBIT $229.5M $337.3M $383.9M $324.6M $233.7M
 
Revenue (Reported) $4.5B $4.8B $5.6B $5.8B $5.8B
Operating Income (Reported) $226.9M $335.4M $371.2M $316M $209.9M
Operating Income (Adjusted) $229.5M $337.3M $383.9M $324.6M $233.7M
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Revenue $3.7B $4.2B $4.3B $4.2B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.7B $3.2B $3.3B $3.2B --
Gross Profit $962.2M $1.1B $1B $1B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $714.5M $514.8M $276.2M $289.8M --
Other Inc / (Exp) $4.6M $5.4M $6.8M $19.5M --
Operating Expenses $714.5M $772.2M $816M $860.8M --
Operating Income $247.7M $278.8M $219.2M $139.6M --
 
Net Interest Expenses $18.1M $16.1M $16.1M $16.7M --
EBT. Incl. Unusual Items $234.1M $268.1M $209.9M $142.5M --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $56.2M $65.5M $51.7M $35.5M --
Net Income to Company $178M $202.6M $158.2M $107M --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $178M $202.6M $158.2M $107M --
 
Basic EPS (Cont. Ops) $9.26 $10.92 $8.51 $5.76 --
Diluted EPS (Cont. Ops) $9.03 $10.66 $8.32 $5.63 --
Weighted Average Basic Share $59.5M $56.5M $57M $57M --
Weighted Average Diluted Share $59.5M $57M $57M $57M --
 
EBITDA $343.2M $372.7M $312.8M $246.7M --
EBIT $252.3M $284.2M $226M $159.1M --
 
Revenue (Reported) $3.7B $4.2B $4.3B $4.2B --
Operating Income (Reported) $247.7M $278.8M $219.2M $139.6M --
Operating Income (Adjusted) $252.3M $284.2M $226M $159.1M --
Period Ending 2019-09-30 2020-09-30 2021-09-30 2022-09-30 2023-09-30
Cash and Equivalents $42.1M $6.9M $70.3M $267.2M $328.5M
Short Term Investments -- -- $5M -- --
Accounts Receivable, Net $72M $81.4M $95.1M $97.2M $107.6M
Inventory $374.1M $366.8M $390M $457.9M $493.9M
Prepaid Expenses -- -- -- -- --
Other Current Assets $8.9M $15.1M $15.1M $15.8M $22.6M
Total Current Assets $497.1M $470.2M $575.4M $838.1M $952.6M
 
Property Plant And Equipment $1.3B $1.4B $1.4B $1.4B $1.5B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $26M $28M $32M $44.8M $49.8M
Total Assets $1.9B $1.9B $2B $2.3B $2.5B
 
Accounts Payable $151.3M $204.1M $189.4M $213.4M $204M
Accrued Expenses $21.5M $14.1M $12M $12.5M $15.4M
Current Portion Of Long-Term Debt $12.6M $19.3M $17.6M $17.6M $17.5M
Current Portion Of Capital Lease Obligations -- $8.4M $8.6M $7.8M $8.2M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $247.6M $323.8M $306.1M $333.8M $330.5M
 
Long-Term Debt $839.6M $586.2M $571.9M $554.3M $532.6M
Capital Leases -- -- -- -- --
Total Liabilities $1.2B $1.1B $1B $1B $1B
 
Common Stock $1M $1M $949.7K $949.7K $949.7K
Other Common Equity Adj -$1.3M -$10.3M -$3.4M $12.4M $13.2M
Common Equity $662.7M $819.3M $983.3M $1.3B $1.5B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $662.7M $819.3M $983.3M $1.3B $1.5B
 
Total Liabilities and Equity $1.9B $1.9B $2B $2.3B $2.5B
Cash and Short Terms $42.1M $6.9M $75.3M $267.2M $328.5M
Total Debt $852.2M $605.5M $589.5M $571.9M $550.2M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Cash and Equivalents $152.1M $24.5M $126M $280.7M $354.8M
Short Term Investments -- $295M $115.2M -- --
Accounts Receivable, Net $77M $90.2M $99.4M $100.8M $99.6M
Inventory $355.5M $380.5M $418.6M $482M $483.5M
Prepaid Expenses -- -- -- -- --
Other Current Assets $11.6M $10.3M $19.9M $33.2M $24.8M
Total Current Assets $596.2M $800.4M $779.1M $896.7M $962.7M
 
Property Plant And Equipment $1.4B $1.4B $1.4B $1.5B $1.5B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $27.6M $32.3M $40.8M $47.5M $51.3M
Total Assets $2B $2.2B $2.2B $2.4B $2.5B
 
Accounts Payable $167M $180.2M $211.9M $203.8M $208.4M
Accrued Expenses $11.1M $5.6M $5.1M $6.3M $6.9M
Current Portion Of Long-Term Debt $168.9M $314.5M $17.6M $17.5M $17.5M
Current Portion Of Capital Lease Obligations $8.1M $8.6M $8M $7.2M $6.7M
Other Current Liabilities $13.7M $13.9M $13.1M $13.1M $15.7M
Total Current Liabilities $428M $585.6M $319.4M $313.2M $322.4M
 
Long-Term Debt $650.3M $586.7M $557.6M $535.9M $518.3M
Capital Leases -- -- -- -- --
Total Liabilities $1.2B $1.3B $1B $999.8M $991.9M
 
Common Stock $1M $949.7K $949.7K $949.7K $949.7K
Other Common Equity Adj -$10.8M -$3.7M $8.7M $11.2M $10.3M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $764.2M $914.3M $1.2B $1.4B $1.6B
 
Total Liabilities and Equity $2B $2.2B $2.2B $2.4B $2.5B
Cash and Short Terms $152.1M $319.5M $241.3M $280.7M $354.8M
Total Debt $819.3M $901.2M $575.2M $553.4M $535.9M
Period Ending 2019-09-30 2020-09-30 2021-09-30 2022-09-30 2023-09-30
Net Income to Stockholders $81.6M $178.6M $249.7M $272.8M $210.8M
Depreciation & Amoritzation $112.5M $116.3M $117.1M $117.8M $116M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$1.9M -$9.4M -$13.7M -$2.1M -$10.4M
Change in Inventories -$1.9M $7.3M -$23.1M -$68M -$35.9M
Cash From Operations $211.5M $350.1M $306.3M $339.5M $266.4M
 
Capital Expenditures $161.8M $122.8M $140.6M $119.6M $173.6M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$152.8M -$117.4M -$128M -$112M -$170.1M
 
Dividends Paid (Ex Special Dividend) -$13M -$13M -$12.6M -$12.3M -$12.3M
Special Dividend Paid
Long-Term Debt Issued $303.8M $267.8M $1B -- --
Long-Term Debt Repaid -$317.9M -$522M -$1B -$18.4M -$22.7M
Repurchase of Common Stock -- -- -$80M -- --
Other Financing Activities -- -$854.8K -$5.6M -- --
Cash From Financing -$27.1M -$268M -$114.9M -$30.6M -$35M
 
Beginning Cash (CF) $10.5M $42.1M $6.9M $70.3M $267.2M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $31.6M -$35.2M $63.4M $196.9M $61.3M
Ending Cash (CF) $42.1M $6.9M $70.3M $267.2M $328.5M
 
Levered Free Cash Flow $49.8M $227.3M $165.7M $219.9M $92.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $57.9M $71.7M $70.2M $52.6M --
Depreciation & Amoritzation $30M $26.2M $29.3M $29.2M --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$4.3M -$4.9M $2.2M -$6.7M --
Change in Inventories -$11.3M -$9.5M -$39.4M -$11.9M --
Cash From Operations $121.2M $92.4M $77.9M $89.4M --
 
Capital Expenditures $43.9M $32.6M $46.4M $36.5M --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$45.7M $268.5M $69.8M -$34.9M --
 
Dividends Paid (Ex Special Dividend) -$3.3M -$3.1M -$3.1M -$3.1M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $112.8M -- -- -- --
Long-Term Debt Repaid -$330.2M -$311.6M -$3.5M -$3.7M --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -$336.9K -- -- --
Cash From Financing -$220.6M -$315M -$6.5M -$6.7M --
 
Beginning Cash (CF) $152.1M $24.5M $126M $280.7M --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$145.2M $45.8M $141.2M $47.8M --
Ending Cash (CF) $6.9M $70.3M $267.2M $328.5M --
 
Levered Free Cash Flow $77.3M $59.7M $31.5M $52.9M --
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Net Income to Stockholders $141.7M $235.9M $274.3M $228.3M $159.7M
Depreciation & Amoritzation $115.2M $120.9M $114.7M $116.1M $116.7M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $791.6K -$13.2M -$9.2M -$1.5M $1.3M
Change in Inventories $12.6M -$25M -$38.1M -$63.4M -$1.6M
Cash From Operations $296M $335.1M $354M $254.9M $278.7M
 
Capital Expenditures $117.4M $151.8M $105.8M $183.5M $179.5M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$109.4M -$442.2M $86.7M -$65.4M -$173.4M
 
Dividends Paid (Ex Special Dividend) -$13M -$12.8M -$12.3M -$12.3M -$12.3M
Special Dividend Paid
Long-Term Debt Issued $155M $1.1B -- -- --
Long-Term Debt Repaid -$194.1M -$1B -$326.5M -$22.5M -$19M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -$53M -$20.6M -$339.1M -$34.7M -$31.3M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $133.6M -$127.7M $101.6M $154.7M $74M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $178.5M $183.2M $248.2M $71.3M $99.2M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $249.7M $272.8M $210.8M $107M --
Depreciation & Amoritzation $117.1M $117.8M $116M $87.5M --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$13.7M -$2.1M -$10.4M $8M --
Change in Inventories -$23.1M -$68M -$35.9M $10.3M --
Cash From Operations $306.3M $339.5M $266.4M $189.3M --
 
Capital Expenditures $140.6M $119.6M $173.6M $143M --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$128M -$112M -$170.1M -$138.5M --
 
Dividends Paid (Ex Special Dividend) -$12.6M -$12.3M -$12.3M -$9.2M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1B -- -- -- --
Long-Term Debt Repaid -$1B -$18.4M -$22.7M -$15.3M --
Repurchase of Common Stock -$80M -- -- -- --
Other Financing Activities -$5.6M -- -- -- --
Cash From Financing -$114.9M -$30.6M -$35M -$24.5M --
 
Beginning Cash (CF) $50.2M $289.6M $1.1B $905.6M --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $63.4M $196.9M $61.3M $26.2M --
Ending Cash (CF) $113.6M $486.5M $1.1B $931.8M --
 
Levered Free Cash Flow $165.7M $219.9M $92.8M $46.2M --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock